Tag: Ph.D.

Curis, Inc. Announces 2021 Virtual Symposium: “VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond”

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the virtual symposium, “VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond,” taking place on June 18, 2021, 9:00-1:15 PM ET. Leaders in immunology across industry and academia will gather to discuss emerging checkpoint molecule, VISTA, including its function, the role it… Read more »

New integrated, outpatient program created to combat mental illness, homelessness

To help break the cycle of mental illness, addiction and homelessness, The University of Texas Health Science Center at Houston (UTHealth) has launched a new integrated, trauma-informed behavioral health program for treatment and recovery support. The UTHealth Homeless Outpatient Mental Health Expansion Services Program is funded with a $2.5 million grant from the Substance Abuse and Mental Health Services Administration of the U.S. Department… Read more »